/ -- Novasep, a leading supplier of services and technologies for the life sciences industry, announces Enzene Biosciences (India) has chosen BioSC Pilot for purification of biopharmaceuticals to operate in its Pune plant.
(Logo: https://mma.prnewswire.com/media/815661/Novasep_Logo.jpg )
"The growing demand for biopharmaceuticals and the constant pressure on productivity leads the biotech industry to rethink their manufacturing practices," said Nadge Laborde, President of Novasep's Process Solutions Business Unit. "BioSC Pilot is the perfect asset to help our customers implement continuous and intensified manufacturing for their downstream processes and reduce the time-to-market of their products."
For press information, click here: https://www.novasep.com/press-release-about-novasep.html
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
